Member Info for EmeraldCarrots

TwoGood2Die.

I was hoping you had been banned from here, but LSE still let you post here for some reason.

Back to AGL and I must say I am disappointed the sp has slowly declined over the months to where it is now. The lack of news over the last 3 or 4 months is clearly to blame (since the placing). The sales team at Angle need to do better. The contracts with Astrazeneca and Eisai should have given their sales team a massive boost with the cancer drug trial monitoring side. Nothing yet......... Sales of the Parsortix machine, the Parsortix consumables, the assays Angle have now finally developed etc... we probably won't get news on until a trading update. Until we get that we will no doubt get people making things up out of thin air and posting it on here.

The only good news is it has been months since the last good news RNS, so presumably the next one is quite close. I have some new one’s sub 13p. Another Astrazeneca type RNS would do nicely to probably spike the sp over 25p. We know Mr Newland was/is talking to some “household” names……….

All IMHO.

Evidence, and you won't have.

"We have ooh so many great distributors across many countries. They’ve been in place now for how long? Over a year? Not one has managed to place an order. Not one.".

Do you want to get banned from this site?

This document is a good example of why NICE should be overhauled and streamlined. No wonder the NHS is wasting so much money. Reading it you can see it is written by lawyers who are covering the NHS against any slight whiff of legal action. Anyone would need to read this document numerous times to fully understand it.

In layman’s terms I think it says this............probably:-

1. You can use the Genedrive CYP2C19 ID to find out in only an hour if the clopidogrel antiplatelet treatment (the most recommended treatment) will work or not. If the result says it won’t, do a blood draw and ask for a lab test to confirm. In the meantime, immediately start alternative treatment. Don’t wait for the lab result.

2. If you don't use Genedrive CYP2C19 ID you can do a blood draw instead and wait a few days for the lab result. In the meantime, what should you do? It does not seem to say.......................?????????

A). Does the medic administer clopidogrel and hope that it will work while they wait a few days for the result from the lab?

B) Or do they use aspirin or some other less recommended alternative for the antiplatelet treatment while they wait for the result of the lab test?

C) Doing nothing is NOT an option as it says *****Starting antiplatelet treatment should not be delayed while waiting for test results*****.

I think Genedrive should contact NICE to get clarification on what the medic should do while waiting for the result of the lab test if they choose that option.

It is very unclear.

Comments welcome.

https://www.nice.org.uk/guidance/dg59/chapter/1-Recommendations

All IMHO.

Diagnostics guidance [DG59] Published: 31 July 2024.

From the document:-

"What this means in practice

This guidance does not replace existing guidance on antiplatelet therapy when genotype testing is not available, or when results from testing have not been received. *****Starting antiplatelet treatment should not be delayed while waiting for test results*****."

The Genedrive CYP2C19 ID Kit point-of-care test gives the result is about an hour. The lab tests take days. Therefore, starting the recommended Antiplatelet treatment (clopidogrel) most certainly WILL BE DELAYED waiting for a result from a lab. In practice waiting for the result of a lab test is impractical. The medics will immediately realise this and ask for a Genedrive CYP2C19 ID Kit to use. This seems totally obvious.

https://www.nice.org.uk/guidance/dg59/chapter/1-Recommendations

All IMHO.

Look at holding for up to 8 weeks. So long since ANY good news....... but things are happening.

All IMHO...........

Director buy(s), trust(s) other then the Manchester one placing a order(s), etc.....

News on international sales of the hearing one......?

New distribution partners........

Any day IMHO.

Good RNS's.

What's the betting AGL shares will spike to 30p plus at some point in the next 3 months?

When you can invest for a while you reap the benefits.

I will post when I sell some and make a shed load. Again.

Warning you harp on about every time you post. Is that because it does not exist? LOL! Is that a YES, it does NOT exist?? LOL!

If any have bought today then any time now or early tomorrow mornning would be my guess.

GDR seems to on the verge of a complete turnaround.

Going up. LOL!

Another direcor buy??

Hmm.

Or has stopped.

Why is the ask **NOT** now 2.75p......... some trades hae gone through at that....

==========================

There u go. Ask now 2.75p. Do we have to point this out!!!!!!!!!!!!!!!! LOL!

Why is the ask **NOT** now 2.75p......... some trades hae gone through at that....

Why is the ask now 2.75p......... some trades hae gone through at that....

When the chairman bought the 1,000,000 shares on the 15th for £31,000 he could do because all market sensitive information was in the public domain via the RNS's which had already been released. As I posted before he actually bought. So if we have a massive influx of orders due to the NICE recommendation he is in the clear.

Fevertreeman.

Clearly back in 2022 the Directors thought the Parsortix machine would sell very well. It did not and one of the main reasons was to make use of the circulating tumour cells (CTC's) you also need to know what you want to test them for and produce an assay test to enable that to happen. This costs a lot of money. 99% of the CTC's the machine catches are alive and intact so they could not be better test subjects. This is a huge plus for the Parsortix machine.

Angle have now produced some of their own assays. DNA damage response, Portrait PD-L1 etc. The big Pharma Co's have been very reluctant to play their part, presumably down to the cost?

Finally, we now have Eisai Inc. of Japan and Astrazeneca paying Angle to produce assays to enable testing of the CTC's during cancer drug trials. This is I think what Angle expected to happen during 2023, and we got almost nothing!! With Astra and Eisai finally reaching for their cheque books this year It seems a salesman dream to build on to get contracts with other Companies. Frankly, I am disappointed no other Plc's have yet followed Eisai or Astrazeneca. Mr Newland said earlier in the year that he is speaking to other Plc's. I am extremely surprised we have still not had an RNS to say another massive Plc is on board. These big Plc's should be helping Angle by sorting out what they want to test in the CTC's during their cancer drug trials, then paying Angle to produce the assay to do the test. This must be holding cancer research back.

It seems to me if any cancer drug trial involves metastasised cancer, then surely the Plc must test for the drugs effect on them. NOT doing this seems absurd. There simply must be other Plc’s out there that will get Angle on board. The time it has taken is shocking.

All IMHO.